Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elekta AB Receives U.S. FDA 510(k) Clearance Following Launch Of New Versa HD Radiation Therapy System For Cancer Treatment


Thursday, 11 Apr 2013 05:13am EDT 

Elekta AB announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the Company to begin shipping and installation of all components of the Versa HD system within the United States. 

Company Quote

73.175
0.475 +0.65%
9:48am EDT